Literature DB >> 27108965

Autoinflammation: When is familial Mediterranean fever 'severe'?

Helen J Lachmann1, Paul A Brogan2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27108965     DOI: 10.1038/nrrheum.2016.55

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  9 in total

1.  Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.

Authors:  Fehime Kara Eroglu; Nesrin Beşbaş; Rezan Topaloglu; Seza Ozen
Journal:  Rheumatol Int       Date:  2015-05-23       Impact factor: 2.631

2.  Familial Mediterranean fever: risk factors, causes of death, and prognosis in the colchicine era.

Authors:  Servet Akar; Feride Yuksel; Mehmet Tunca; Ozgul Soysal; Dilek Solmaz; Vedat Gerdan; Ali Celik; Gercek Sen; Fatos Onen; Nurullah Akkoc
Journal:  Medicine (Baltimore)       Date:  2012-05       Impact factor: 1.889

3.  Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study.

Authors:  Mehmet Tunca; Servet Akar; Fatos Onen; Huri Ozdogan; Ozgur Kasapcopur; Fatos Yalcinkaya; Ercan Tutar; Seza Ozen; Rezan Topaloglu; Engin Yilmaz; Mustafa Arici; Aysin Bakkaloglu; Nesrin Besbas; Tekin Akpolat; Ayhan Dinc; Eren Erken
Journal:  Medicine (Baltimore)       Date:  2005-01       Impact factor: 1.889

Review 4.  Colchicine: 1998 update.

Authors:  E Ben-Chetrit; M Levy
Journal:  Semin Arthritis Rheum       Date:  1998-08       Impact factor: 5.532

5.  EULAR recommendations for the management of familial Mediterranean fever.

Authors:  Seza Ozen; Erkan Demirkaya; Burak Erer; Avi Livneh; Eldad Ben-Chetrit; Gabriella Giancane; Huri Ozdogan; Illana Abu; Marco Gattorno; Philip N Hawkins; Sezin Yuce; Tilmann Kallinich; Yelda Bilginer; Daniel Kastner; Loreto Carmona
Journal:  Ann Rheum Dis       Date:  2016-01-22       Impact factor: 19.103

6.  Mortality risk factors associated with familial Mediterranean fever among a cohort of 1.25 million adolescents.

Authors:  Gilad Twig; Avi Livneh; Asaf Vivante; Arnon Afek; Ari Shamiss; Estela Derazne; Dorit Tzur; Ilan Ben-Zvi; Amir Tirosh; Micha Barchana; Tamy Shohat; Eliezer Golan; Howard Amital
Journal:  Ann Rheum Dis       Date:  2013-03-16       Impact factor: 19.103

7.  Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome.

Authors:  Hao Xu; Jieling Yang; Wenqing Gao; Lin Li; Peng Li; Li Zhang; Yi-Nan Gong; Xiaolan Peng; Jianzhong Jeff Xi; She Chen; Fengchao Wang; Feng Shao
Journal:  Nature       Date:  2014-06-11       Impact factor: 49.962

8.  Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF).

Authors:  Erkan Demirkaya; Cengizhan Acikel; Philip Hashkes; Marco Gattorno; Ahmet Gul; Huri Ozdogan; Turker Turker; Omer Karadag; Avi Livneh; Eldad Ben-Chetrit; Seza Ozen
Journal:  Ann Rheum Dis       Date:  2016-01-28       Impact factor: 19.103

9.  Global epidemiology of Familial Mediterranean fever mutations using population exome sequences.

Authors:  Kohei Fujikura
Journal:  Mol Genet Genomic Med       Date:  2015-04-05       Impact factor: 2.183

  9 in total
  4 in total

1.  Detection of Familial Mediterranean Fever attacks by using a connected activity tracker and assessment of impact of attacks to daily physical activities: a pilot study.

Authors:  Hakan Babaoglu; Ozkan Varan; Nuh Atas; Hasan Satis; Reyhan Salman; Mehmet Akif Ozturk; Berna Goker; Seminur Haznedaroglu; Abdurrahman Tufan
Journal:  Clin Rheumatol       Date:  2019-03-02       Impact factor: 2.980

2.  Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis and Monogenic Autoinflammatory Diseases at a National Referral Center.

Authors:  Claire J Peet; Dorota Rowczenio; Ebun Omoyinmi; Charalampia Papadopoulou; Bella Ruth R Mapalo; Michael R Wood; Francesca Capon; Helen J Lachmann
Journal:  J Am Heart Assoc       Date:  2022-06-06       Impact factor: 6.106

Review 3.  [Evidence-based treatment recommendations for familial Mediterranean fever : A joint statement by the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology].

Authors:  T Kallinich; N Blank; T Braun; E Feist; U Kiltz; U Neudorf; P T Oommen; C Weseloh; H Wittkowski; J Braun
Journal:  Z Rheumatol       Date:  2019-02       Impact factor: 1.372

4.  [Results of the systematic literature search as basis for the "Evidence-based treatment recommendations for familial Mediterranean fever patients with insufficient response or intolerability to colchicine" of the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology].

Authors:  T Sahr; U Kiltz; C Weseloh; T Kallinich; J Braun
Journal:  Z Rheumatol       Date:  2020-09-30       Impact factor: 1.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.